Outset Medical, Inc. Restricted Cash
Outset Medical, Inc. (OM) had Restricted Cash of $3.83 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCash · last filed 2026-08-06
- 2026-06-30: Restricted Cash $3.83M.
- 2026-03-31: Restricted Cash $3.83M.
- 2025-12-31: Restricted Cash $3.83M.
- 2025-09-30: Restricted Cash $3.33M.
| Period end | Restricted Cash |
|---|---|
| 2026-06-30 | $3.83M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $3.83M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $3.83M 10-K · filed 2026-02-13 |
| 2025-09-30 | $3.33M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $3.33M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $3.33M 10-Q · filed 2026-05-07 |
| 2024-12-31 | $3.33M 10-K · filed 2026-02-13 |
| 2024-09-30 | $3.33M 10-Q · filed 2025-11-10 |
| 2024-06-30 | $3.33M 10-Q · filed 2025-08-07 |
| 2024-03-31 | $3.33M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $3.33M 10-K · filed 2026-02-13 |
| 2023-09-30 | $3.33M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $3.33M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $3.31M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $3.31M 10-K · filed 2025-02-28 |
| 2022-09-30 | $33.31M 10-Q · filed 2023-11-08 |
| 2022-06-30 | $33.31M 10-Q · filed 2023-08-03 |
| 2022-03-31 | $33.31M 10-Q · filed 2023-05-04 |
| 2021-12-31 | $33.31M 10-K · filed 2024-02-21 |
| 2021-09-30 | $33.31M 10-Q · filed 2022-11-09 |
| 2021-06-30 | $33.31M 10-Q · filed 2022-08-02 |
| 2021-03-31 | $33.31M 10-Q · filed 2022-05-05 |
| 2020-12-31 | $33.31M 10-K · filed 2023-02-13 |
| 2019-12-31 | $743.00K 10-K · filed 2022-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |